Navigation Links
Medical Researchers Say They Have Made a Breakthrough That Could Lead to a Potential Cure for AIDS
Date:9/1/2013

Auckland, NZ (PRWEB) September 01, 2013

Dr Richard Teague, spokesperson for Regenex Laboratories, says they have discovered how to use selected proteins within an ovine placenta extract base and combine it with peptides and signaling molecules designed to ‘wake up’ dormant stem cells in the body.

"Peptides are considered the future of medicine," he said. "And with this technology, using fractionated OVP in combination with peptides, we can provide an answer to HIV by reactivating the patient’s immune system."

"Up until now these products have only used in the controversial anti-ageing field, but now we have evidence that they actually do re-activate a person's stem cells. The stem cells are intelligent in that they seek out the area of most need in the body and repair it."

Dr Teague says the injectable cannot eradicate HIV from the body but it could potentially end the disease, as it provides a healthy immune system so patients can handle normal infections."

More than 33 million people have been diagnosed with HIV worldwide.

If clinical trials are successful, one initial 12 week course followed by a single dose every 3-4 months could be effective enough to replace the multiple therapies they currently need.

The key to the Immune Booster IM product is the filtering process which is used in the production process. The company has been able to achieve a filtration of less than 50,000 Dalton units, meaning the 5mg dose can be safely injected intramuscular, rather than having to be done intravenously.

"We have spent several years developing the production process and this is cutting edge technology now available to consumers worldwide."

"With HIV you have 2 options. You either have to eliminate the virus infection from the body, or you have to provide the body a mechanism by which it can naturally fight off simple diseases which to a HIV sufferer can be fatal. Immune Booster IM does that by activating dormant stem cells."

Dr Teague says that while the product is readily available now for anti ageing, and other conditions such as Rheumatoid arthritis and crones disease, the product is yet to undergo trials for HIV.

"This particular study is going to take some time, but so far every test that we have put this product through has passed with flying colors, and we have enough initial human tests results to know we have something special here," he said.

Successful clinical trials would present a rare bright spot in the ongoing battle against HIV. In August this year, U.S. trials for a potential AIDS vaccine were called off after the National Institute of Allergy and Infectious Diseases found the treatment — HVTN 505 —statistically ineffective compared to a placebo. (A cure differs from a vaccine in that the former works on people who have already contracted the virus.)

Immune Booster IM will be marketed as a cure since early trials indicate it has the ability to completely reverse the AIDS potency in the body, by boosting T-Cell counts and decreasing viral load. This comes about by the body itself fighting off the disease, after being re-activated by the Immune Booster IM.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11082049.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Physician Groups Call for Fewer Medical Tests
2. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
3. CAM therapy combined with conventional medical care may improve treatment of lower back pain
4. Image share project gives patients and physicians anytime, anywhere access to medical images
5. Researchers determine vitamin D blood level for reducing major medical risks in older adults
6. Biomedical researchers receive Hartwell Foundation awards
7. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
8. Fitness in Middle Age Lowers Medical Costs Later: Study
9. Ben-Gurion U. and Cincinnati Childrens Hospital to develop pediatric-specific medical technologies
10. Gene Tests May Not Drive Patients to More Medical Care
11. University studies and career expectations of medical students
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 24, 2017 , ... Congratulations to Head Over Heels’ elite ... 12th. Ms. Esparza qualified into this prestigious status after winning the Vault, ... Vegas, Nevada. Frida is one of approximately 25 gymnasts in the nation who ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most ... Jensie Gran Fondo of Marin. For the second year in a row, cyclists ... sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen to over ...
(Date:2/23/2017)... CO (PRWEB) , ... February 23, 2017 , ... The ... announce the winner of the 2016 National Education Policy Center Bunkum Award. We invite ... reviewed in 2016. , This year’s Bunkum winner is the Center for American Progress ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease ... will be participating in Rare Disease Day events, hosted by the Rare Disease ... Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews ...
(Date:2/23/2017)... Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... first two episodes of WE TV’s “Mama June: From Not to Hot,” which will ... TV notable, “Mama” June Shannon, known to millions from the 2012 reality television series, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - 2016, provides ... research answers the following questions: What are ... they positioned in the Global Menopause market? What are ...
(Date:2/23/2017)... , Feb. 23, 2017 Research and ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... data and benchmarks in the global Fibromyalgia market. The ... the key drugs marketed for Fibromyalgia and their clinical attributes? How ...
(Date:2/23/2017)... 23, 2017 Obese people are ... for varicose veins in their body. The rising number ... the adoption of endovenous laser therapy for treatment of ... laser therapy market, published by Future Market Insights, ... and consequences of obesity have collectively factored the growth ...
Breaking Medicine Technology: